Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alastair Matheson

Showing results (1-10 of 15) with videos related to

Pageof 2
Sort By:
The Hastings Center Report|July 16, 2016
The Disposable Author: How Pharmaceutical Marketing Is Embraced within Medicine's Scholarly LiteratureAlastair Matheson
American Journal of Public Health|February 20, 2010
Five steps for structural reform in clinical cancer researchAlastair Matheson
Accountability in Research|January 5, 2019
Can self-regulation deliver an ethical commercial literature? A critical reading of the "Good Publication Practice" (GPP3) guidelines for industry-financed medical journal articlesAlastair Matheson
Trials|March 9, 2017
Marketing trials, marketing tricks - how to spot them and how to stop themAlastair Matheson
Indian Journal of Medical Ethics|June 14, 2022
Attribution and credit bias in publication ethicsAlastair Matheson
Accountability in Research|July 10, 2023
The "Monsanto papers" and the nature of ghostwriting and related practices in contemporary peer review scientific literatureAlastair Matheson
BMC Medical Ethics|April 6, 2016
The ICMJE Recommendations and pharmaceutical marketing--strengths, weaknesses and the unsolved problem of attribution in publication ethicsAlastair Matheson
American Journal of Public Health|July 15, 2020
Linking Health and Housing Data to Create a Sustainable Cross-Sector PartnershipAmy A Laurent, Alastair Matheson, Katie Escudero, et al.
Public Health Reports (Washington, D.C. : 1974)|September 24, 2025
Accuracy of Suicidal Behaviors in Administrative Data as Measured by <i>International Classification of Diseases, Tenth Revision</i>-Based Codes, 2000-2024: A Rapid ReviewSpencer W Hensley, Precious Esie, Myduc Ta, et al.
Nature Reviews. Clinical Oncology|April 7, 2010
Biomarkers and surrogate end points--the challenge of statistical validationMarc Buyse, Daniel J Sargent, Axel Grothey, et al.
Pageof 2

Showing results (1-10 of 15) with videos related to

Sort By:
Pageof 2
The Hastings Center Report|July 16, 2016
The Disposable Author: How Pharmaceutical Marketing Is Embraced within Medicine's Scholarly LiteratureAlastair Matheson
American Journal of Public Health|February 20, 2010
Five steps for structural reform in clinical cancer researchAlastair Matheson
Accountability in Research|January 5, 2019
Can self-regulation deliver an ethical commercial literature? A critical reading of the "Good Publication Practice" (GPP3) guidelines for industry-financed medical journal articlesAlastair Matheson
Trials|March 9, 2017
Marketing trials, marketing tricks - how to spot them and how to stop themAlastair Matheson
Indian Journal of Medical Ethics|June 14, 2022
Attribution and credit bias in publication ethicsAlastair Matheson
Accountability in Research|July 10, 2023
The "Monsanto papers" and the nature of ghostwriting and related practices in contemporary peer review scientific literatureAlastair Matheson
BMC Medical Ethics|April 6, 2016
The ICMJE Recommendations and pharmaceutical marketing--strengths, weaknesses and the unsolved problem of attribution in publication ethicsAlastair Matheson
American Journal of Public Health|July 15, 2020
Linking Health and Housing Data to Create a Sustainable Cross-Sector PartnershipAmy A Laurent, Alastair Matheson, Katie Escudero, et al.
Public Health Reports (Washington, D.C. : 1974)|September 24, 2025
Accuracy of Suicidal Behaviors in Administrative Data as Measured by <i>International Classification of Diseases, Tenth Revision</i>-Based Codes, 2000-2024: A Rapid ReviewSpencer W Hensley, Precious Esie, Myduc Ta, et al.
Nature Reviews. Clinical Oncology|April 7, 2010
Biomarkers and surrogate end points--the challenge of statistical validationMarc Buyse, Daniel J Sargent, Axel Grothey, et al.
Pageof 2